Perspective
Published on 21 Apr 2021
Gene Therapy: A Possible Alternative to CFTR Modulators?
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.648203
- 14,234 views
- 7 citations
Type at least 3 characters
580 articles
Articles
Mini Review
Published on 20 Apr 2021
Emerging Cell-Based Therapies in Chronic Lung Diseases: What About Asthma?
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.648506
- 4,760 views
- 7 citations
Perspective
Published on 20 Apr 2021
Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.652688
- 133,889 views
- 159 citations
Original Research
Published on 19 Apr 2021
miR-4456/CCL3/CCR5 Pathway in the Pathogenesis of Tight Junction Impairment in Chronic Obstructive Pulmonary Disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.551839
- 4,360 views
- 13 citations
Review
Published on 19 Apr 2021
Research Progress on Strategies that can Enhance the Therapeutic Benefits of Mesenchymal Stromal Cells in Respiratory Diseases With a Specific Focus on Acute Respiratory Distress Syndrome and Other Inflammatory Lung Diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.647652
- 3,347 views
- 13 citations
Original Research
Published on 19 Apr 2021
Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.630334
- 3,147 views
- 6 citations
Original Research
Published on 15 Apr 2021
Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.663551
- 7,328 views
- 53 citations
Review
Published on 15 Apr 2021
Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.645558
- 5,099 views
- 12 citations
Mini Review
Published on 15 Apr 2021
Cystic Fibrosis Lung Disease in the Aging Population
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.601438
- 7,501 views
- 11 citations
Original Research
Published on 12 Apr 2021
Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.639574
- 4,544 views
- 19 citations
Original Research
Published on 12 Apr 2021
Potential Mechanism Prediction of Herbal Medicine for Pulmonary Fibrosis Associated with SARS-CoV-2 Infection Based on Network Analysis and Molecular Docking
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.602218
- 6,031 views
- 12 citations
Editorial
Published on 12 Apr 2021
Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.657596
- 1,841 views
- 2 citations
Original Research
Published on 05 Apr 2021
Possible Tracheal Relaxant and Antimicrobial Effects of the Essential Oil of Ethiopian Thyme Species (Thymus serrulatus Hochst. ex Benth.): A Multiple Mechanistic Approach
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.615228
- 4,965 views
- 5 citations
Original Research
Published on 30 Mar 2021
Brusatol Derivative–34 Attenuates Allergic Airway Inflammation Via Inhibition of the Spleen Tyrosine Kinase Pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.587417
- 2,346 views
- 6 citations
Original Research
Published on 25 Mar 2021
Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.646676
- 14,051 views
- 49 citations
Original Research
Published on 23 Mar 2021
COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.633680
- 188,640 views
- 84 citations